
Read More
Mankind Pharma Reports Q4FY26 Results; PAT Jumps 32% YoY, Revenue Crosses R...
Mankind Pharma reported Q4FY26 revenue growth of 11.8 per cent YoY to Rs 3,443 crore, while quarterl...

Mankind Pharma reported Q4FY26 revenue growth of 11.8 per cent YoY to Rs 3,443 crore, while quarterl...

Board Approves Closure of Sri Lanka Subsidiary Citing Regulatory Changes...

We are working on strengthening our consumer healthcare business via new launches, premiumisation an...